chr3-10146640-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000551.4(VHL):c.463+4C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000551.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHL | NM_000551.4 | c.463+4C>G | splice_region_variant, intron_variant | ENST00000256474.3 | NP_000542.1 | |||
VHL | NM_001354723.2 | c.*18-3147C>G | intron_variant | NP_001341652.1 | ||||
VHL | NM_198156.3 | c.341-3147C>G | intron_variant | NP_937799.1 | ||||
VHL | NR_176335.1 | n.792+4C>G | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VHL | ENST00000256474.3 | c.463+4C>G | splice_region_variant, intron_variant | 1 | NM_000551.4 | ENSP00000256474.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The c.463+4C>G intronic variant results from a C to G substitution 4 nucleotides after coding exon 2 in the VHL gene. This alteration was detected in a family with history of hemangioblastoma and pheochromocytoma with reduced penetrance (Sexton A et al. J Genet Couns, 2015 Dec;24:882-9). In a functional RNA study, this alteration was seen with increased in-frame skipping of exon 2 relative to normal controls in an agarose gel (Sexton A et al. J Genet Couns, 2015 Dec;24:882-9). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive, and direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.